VectraCor, Inc.
Diagnosing Better Care
Company Overview

VectraCor is a medical device company headquartered in Totowa, NJ with a disruptive patented technology for the number 1 killer in the world, Cardiovascular Disease (heart attacks). We are the first company in the world to detect a heart attack, noninvasively in real time with our CEBĀ®, Cardiac Electrical Biomarker, and derive a 15 - 22 lead ECG with only 5 electrodes on the patient (current technology uses 10 electrodes and provides only a12 lead ECG). This is a major advancement from the current protocol of managing Chest Pain patients in both hospital (clinical settings ) as well as consumer markets.

FDA Approval - CE Mark - Australian Approval - Taiwan Approval

Company URL